Abstract
This chapter presents an overview of how decision-making processes for the reimbursement for new medicines have evolved in Taiwan over the last 20 years and how patient involvement has developed since it began in 2015. It outlines patient participation in the HTA programme that informs medicine reimbursement. It shows how Taiwan is encouraging patient participation in HTA via online submissions, participation in committee meetings and educational events and continues to develop its participation processes. The chapter highlights the challenges of patient participation in a setting where patient groups have little experience of engagement in policy. It also points to the need for guidance on using patient-based evidence in HTA and the potential value of resources that can be adapted to meet local needs and support HTA bodies developing patient involvement programmes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
CADTH-pCODR. pan-Canadian oncology drug review: patient engagement guide. 2015. https://www.cadth.ca/sites/default/files/pcodr/pCODR%27s%20Drug%20Review%20Process/pcodr-patient-engagement-guide.pdf. Accessed 1 Mar 2016.
HTAi. HTAi Patient group submission template for medicines and non-medicines. 2014a. http://www.htai.org/interest-groups/patient-and-citizen-involvement/resources/for-patients-and-patient-groups.html. Accessed 1 Mar 2016.
HTAi. HTAi values and quality standards for patient & citizen involvement in HTA. 2014b. http://www.htai.org/interest-groups/patient-and-citizen-involvement/resources/for-patients-and-patient-groups.html. Accessed 1 Mar 2016.
Ministry for Justice. The National Health Insurance pharmaceutical benefits and reimbursement schedule. 2013. http://law.moj.gov.tw/Eng/LawClass/LawAll.aspx?PCode=L0060035 Accessed 1 Mar 2016.
Ministry for Justice. Article 41 and 42. In: National Health Insurance Act. 2011. http://law.moj.gov.tw/Eng/LawClass/LawAll.aspx?PCode=L0060001. Accessed 1 Mar 2016.
National Health Insurance Administration in Taiwan. About NHI. 2015. http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu_id=290&webdata_id=2974&WD_ID=290. Accessed 1 Mar 2016.
National Health Insurance Administration in Taiwan. NHIA webpage for patient, care giver and patient groups sharing opinions. (In Chinese). 2016. http://www.nhi.gov.tw/PatientShare/PatientShare.aspx. Accessed 1 Mar 2016.
pan-Canadian oncology drug review. pCODR patient advocacy group input on a drug review. 2012. https://www.cadth.ca/sites/default/files/pcodr/pCODR%27s%20Drug%20Review%20Process/pcodr-pad-input-on-drug-review.doc. Accessed 1 Mar 2016.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Tarn, YH.(. (2017). Taiwan. In: Facey, K., Ploug Hansen, H., Single, A. (eds) Patient Involvement in Health Technology Assessment. Adis, Singapore. https://doi.org/10.1007/978-981-10-4068-9_29
Download citation
DOI: https://doi.org/10.1007/978-981-10-4068-9_29
Published:
Publisher Name: Adis, Singapore
Print ISBN: 978-981-10-4067-2
Online ISBN: 978-981-10-4068-9
eBook Packages: MedicineMedicine (R0)